Farzana Muhib

Farzana Muhib brings 20 years of experience in a range of public health disciplines, including disease surveillance, epidemiology, vaccine demand forecasting, vaccine impact and cost-effectiveness modeling, country decision-making and vaccine implementation. While at PATH she has worked on multiple vaccine development (Malaria, ETEC and Shigella) and introduction projects (Japanese Encephalitis, HPV, Typhoid, and COVID-19) to build evidence for global, regional, and country decision-makers to consider when contemplating introduction of vaccines. During the course of her career, Ms. Muhib has worked in Africa, the Middle East and Asia, including Pakistan, Bangladesh, Myanmar, and Mongolia.

Prior to joining PATH, Ms. Muhib worked at Results for Development Institute (R4D), and at Johns Hopkins University on the Pneumococcal Vaccine Accelerated Development and Introduction Project (PneumoADIP).

Ms. Muhib holds an MPH from the Rollins School of Public Health at Emory University, where she concentrated in international health and epidemiology. She also obtained her MA in law and diplomacy from the Fletcher School of Law and Diplomacy at Tufts University, where she concentrated in development economics, and south-west Asian history and Islamic civilizations.